StockNews.com Begins Coverage on InspireMD (NYSE:NSPR)

Investment analysts at StockNews.com began coverage on shares of InspireMD (NYSE:NSPR - Get Free Report) in a research note issued on Friday. The brokerage set a "sell" rating on the stock.

Separately, Lake Street Capital initiated coverage on InspireMD in a research report on Wednesday, December 11th. They set a "buy" rating and a $5.00 price target on the stock.

InspireMD Stock Up 2.8 %

Shares of InspireMD stock traded up $0.08 on Friday, hitting $2.94. The stock had a trading volume of 24,616 shares, compared to its average volume of 26,943. InspireMD has a twelve month low of $1.81 and a twelve month high of $3.42. The business's 50 day moving average is $2.79 and its two-hundred day moving average is $2.73. The stock has a market cap of $76.68 million, a price-to-earnings ratio of -3.92 and a beta of 1.00.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the company. Affiance Financial LLC lifted its stake in shares of InspireMD by 2.9% in the 4th quarter. Affiance Financial LLC now owns 189,122 shares of the company's stock valued at $497,000 after acquiring an additional 5,376 shares during the last quarter. Parkman Healthcare Partners LLC bought a new position in shares of InspireMD in the 3rd quarter valued at $279,000. Legato Capital Management LLC bought a new position in shares of InspireMD in the 4th quarter valued at $47,000. Northern Trust Corp lifted its stake in shares of InspireMD by 103.7% in the 4th quarter. Northern Trust Corp now owns 48,022 shares of the company's stock valued at $126,000 after acquiring an additional 24,452 shares during the last quarter. Finally, Schonfeld Strategic Advisors LLC lifted its stake in shares of InspireMD by 153.2% in the 4th quarter. Schonfeld Strategic Advisors LLC now owns 30,133 shares of the company's stock valued at $79,000 after acquiring an additional 18,233 shares during the last quarter. 44.78% of the stock is currently owned by institutional investors.

About InspireMD

InspireMD, Inc, a medical device company, focuses on the development and commercialization of MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Stent System, a mesh-covered self-expanding carotid stent; and SwitchGuard NPS, a non-invasive transcarotid artery revascularization device; as well as treating acute stroke with tandem lesions.